Systematic review / meta-analysis / 2014
Tea consumption was linked to a lower risk of prostate cancer, particularly in China and India and for low-grade disease.
A meta-analysis of 21 studies was conducted to evaluate the link between tea consumption and prostate cancer (PCa) risk and progression. Pooled results showed a significant association between tea consumption and reduced PCa risk (OR=0.84, 95% CI 0.71-0.98), with reduced risk observed in China (OR=0.40, 95% CI 0.25-0.66) and India (OR=0.48, 95% CI 0.24-0.97). Neither green tea (OR=0.73, 95% CI 0.52-1.02) nor black tea (OR=0.95, 95% CI 0.82-1.11) alone showed a significant effect. The highest level of tea consumption was linked to a protective effect for low-grade PCa (OR=0.66, 95% CI 0.46-0.93), but no significant association was found for localized (OR=1.12, 95% CI 0.82-1.54) or advanced PCa (OR=0.85, 95% CI 0.62-1.16).
Shows an association, not proof of cause and effect.
- Study type
- Meta-analysis
- Who was studied
- Participants across 21 included studies
- What was measured
- Risk and progression of prostate cancer
THE PAPER
The association of tea consumption and the risk and progression of prostate cancer: a meta-analysis.
Fei X, Shen Y, Li X, Guo H. Int J Clin Exp Med, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.